Jonathan Kenneth Kleen

Jonathan Kleen practices at UCSF Helen Diller Medical Center at Parnassus Heights in San Francisco, California, part of University of California Health.

Jonathan Kleen's NPI, 1255673646, was assigned on March 23, 2013. Jonathan Kleen graduated from Geisel School Of Medicine At Dartmouth in 2013. Jonathan Kleen holds California license 134368.

Jonathan Kleen's primary practice is UCSF Helen Diller Medical Center at Parnassus Heights, at 505 Parnassus Ave, Box 0296, San Francisco, CA 94143 in San Francisco County. The practice phone is (415) 353-2733.

Jonathan Kleen's primary practice is UCSF Helen Diller Medical Center at Parnassus Heights in San Francisco, California, part of University of California Health. Jonathan Kleen is also affiliated with Zuckerberg San Francisco General Hospital and Trauma Center. The medical group on file is UCSF Pediatrics. Dmand AI also links Jonathan Kleen to 3 more medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Jonathan Kleen practices, 2 sites in all. Vendor and product names are available with a free account.

Neurology is Jonathan Kleen's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Jonathan Kleen is board certified in epilepsy by the American Board of Psychiatry and Neurology. Jonathan Kleen is licensed in California.

Dmand AI lists epilepsy and seizures among the conditions Jonathan Kleen treats.

CMS data shows 90 Medicare services from Jonathan Kleen across 2 procedure codes in 2024, for 54 Medicare patients. Medicare paid $15,483 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 54 Medicare patients who saw Jonathan Kleen in 2024. The largest group is 65 to 74, with 20 patients. 67% of them have high blood pressure, and 48% have high cholesterol. 69% are also on Medicaid. Their average risk score is 2.02, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Jonathan Kleen's median patient age at 49, with 45% women.

In 2024, Jonathan Kleen wrote 214 Medicare Part D claims for 24 patients. 86% of them were for generic drugs. CMS names the drug for 158 of them, across 8 drugs with 11 or more claims each, at $78,532 in total drug cost. In 2023, CMS named 203 claims across 9 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 97 out of 100 for Jonathan Kleen for performance year 2024, reported as part of a group. Jonathan Kleen accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Jonathan Kleen as offering telehealth.

Dmand AI links 43 papers to Jonathan Kleen, published from 2011 to 2025. 2023 was the busiest year, with 4. The most frequent topics are Electroencephalography, Epilepsy and Seizures. Jonathan Kleen has published most often in Epilepsia. Jonathan Kleen's most frequent co-authors are Edward F. Chang, MD, Vikram Ramnath Rao, MD, PhD and Robert C. Knowlton, MD.

CMS Open Payments shows 1 general payment to Jonathan Kleen from 1 drug or device company in 2016. Food and beverage make up the largest share, 100% of the total. Neuropace, Inc. paid the most, $139.

Jonathan Kleen graduated from Geisel School Of Medicine At Dartmouth in 2013.

Jonathan Kleen is in network with 10 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.